HLA-DMB and endometrioid adenocarcinoma: Additionally, we found that uterine mixed endometrioid carcinoma was most prone to HLA-DMB mutations, followed by endometrial serous carcinoma, which primarily exhibited amplification mutations, and finally endometrioid carcinoma (Figure 7C).